Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen

Tuesday, November 8, 2022 1 min read

Key Takeaway: Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen

Full Press Release Details

Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen.